News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Crescendo Bioscience Announces the U.S. Launch of the First Multi-Biomarker Blood Test for Rheumatoid Arthritis Disease Activity



11/8/2010 10:32:22 AM

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Crescendo Bioscience announced today the commercial launch of Vectra DA, its first-in-class multi-biomarker blood test designed to aid physicians in managing patients with rheumatoid arthritis (RA). Vectra DA analyzes 12 key serum biomarkers to produce a single objective score that quantifies RA disease activity. Launched today at the ACR/ARHP Annual Scientific Meeting , Vectra DA is now available to physicians in 47 states (laboratory licensure has been applied for in Maryland and Rhode Island and is planned for New York).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES